NEW YORK (GenomeWeb News) – MDS said today that it has notified the Toronto Stock Exchange that it may purchase up to roughly 5 percent of the float of its public stock on the TSE and New York Stock Exchange during the next year.

The Toronto-based firm said that during the 12 months commencing July 3, 2008, and ending July 2, 2009, it may purchase up to 4,136,766 MDS common shares on the two exchanges.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.